Back
West Pharmaceutical Services Vs. Perspective Therapeutics Industry Stock Comparison
Buy
52
WST
West Pharmaceutical Services
Last Price:
344.20
Seasonality Move:
4.5%
Sell
30
CATX
Perspective Therapeutics
Last Price:
9.93
Seasonality Move:
28.97%
Buy
52
West Pharmaceutical Services (WST)
is a Buy
Is West Pharmaceutical Services a Buy, Sell or Hold?
- The current West Pharmaceutical Services [WST] share price is $327.68. The Score for WST is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- WST is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $10.67. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
WST Stock Price Chart
What is West Pharmaceutical Services's stock price today?
-
The West Pharmaceutical Services share price today is $327.68
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and WST is experiencing slight buying pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $10.67
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.
WST Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.47 | Buy |
| Relative Strength Index (14 RSI): | 61.18 | Buy |
| Chaikin Money Flow: | 80013 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (290.38 - 322.58) | Buy |
| Bollinger Bands (100): | (293.51 - 320.79) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.45 | Sell |
| Relative Strength Index (14 RSI): | 32.97 | Sell |
| Chaikin Money Flow: | -548254 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.5 - 12.8) | Sell |
| Bollinger Bands (100): | (11.26 - 14.34) | Sell |
WST Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 323.36 | Buy |
| 20-day SMA: | 310.43 | Buy |
| 50-day SMA: | 304.39 | Buy |
| 200-day SMA: | 336.57 | Sell |
| 8-day EMA: | 322.88 | Buy |
| 20-day EMA: | 314.53 | Buy |
| 50-day EMA: | 308.52 | Buy |
| 200-day EMA: | 325.23 | Buy |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.72 | Sell |
| 20-day SMA: | 11.96 | Sell |
| 50-day SMA: | 12.97 | Sell |
| 200-day SMA: | 12.78 | Sell |
| 8-day EMA: | 11.47 | Sell |
| 20-day EMA: | 11.93 | Sell |
| 50-day EMA: | 12.56 | Sell |
| 200-day EMA: | 11.75 | Sell |
West Pharmaceutical Services Earnings Growth & WST Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.46 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.36 per share, and an increase next year of $0.87 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.17 per share.
West Pharmaceutical Services Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||